Cysteamine prevents asthma development and reduces airway hyperresponsiveness in experimental asthma

Allergy. 2020 Oct;75(10):2675-2677. doi: 10.1111/all.14332. Epub 2020 May 6.

Authors

Paige E Bolcas^{1

2}, Eric B Brandt¹, Brandy P Ruff¹, Mehak Kalra¹, Gurjit K Khurana Hershey^{1

3}

Affiliations

¹ Division of Asthma Research, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
² Immunology Graduate Program, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, OH, USA.
³ Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.

PMID: 32311100
DOI: 10.1111/all.14332

No abstract available

Publication types

Letter

MeSH terms

Asthma* / drug therapy
Asthma* / etiology
Asthma* / prevention & control
Bronchial Hyperreactivity* / etiology
Bronchial Hyperreactivity* / prevention & control
Cysteamine / therapeutic use
Humans
Respiration Disorders*
Respiratory Hypersensitivity*

Substances

Cysteamine